We speculated that BLCA and SKCM patients with higher TAP1 expression might indicate higher lymphocyte infiltration in tumors, which usually results the tumor cells more vulnerable under the ICI therapy condition. The gene discussed is TAP1; the disease is bladder transitional cell carcinoma.